STOCKING OZEMPIC 12-13-1022

anonymous

Guest
********Update *******

to the field, we have lost so many patients novo is currently near late 2020 trx volume levels, we have not increased supply, just lost around 200,000 patients in the USA since 08-2022

our plan as ET is to continue to LIE to the field in the hopes that employees will not do simple math

It looks like we increased supply, we have not. We just lost 15-20% of patients on Ozempic.

Oh and goals,…they will increase, especially for the fortunate reps in diabetes. Obesity don’t worry we plan the give you another $80k in IC, DCS u might hit $27k bonus in 2023.

As a bonus we (NNI)now cant figure out how to supply Rybelsus, Novolin, Tresiba u100, Tresiba u200, and Fiasp.

It is all clearly written on email, we just had to connect the dots…